RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
30.39
-0.79 (-2.53%)
At close: Jan 17, 2025, 4:00 PM
30.84
+0.45 (1.48%)
After-hours: Jan 17, 2025, 7:38 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $1.22 billion as of January 21, 2025. Its market cap has decreased by -3.82% in one year.
Market Cap
1.22B
Enterprise Value
999.04M
1-Year Change
-3.82%
Ranking
Category
Stock Price
$30.39
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $1.22B, an increase of 188.65%. That is a compound annual growth rate of 35.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 1.22B | -11.61% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |